These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 6442064)
21. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum. van Schalkwyk DA; Egan TJ Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951 [TBL] [Abstract][Full Text] [Related]
22. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol). Pearlman EJ; Doberstyn EB; Sudsok S; Thiemanun W; Kennedy RS; Canfield CJ Am J Trop Med Hyg; 1980 Nov; 29(6):1131-7. PubMed ID: 7004214 [TBL] [Abstract][Full Text] [Related]
23. [Is it necessary to perform sensitivity tests for malaria in the hospital environment?]. Brandicourt O; Druilhe P; Gentil C; Rosenheim M; Datry A; Danis M; Gentillini M Bull Soc Pathol Exot Filiales; 1986; 79(3):352-9. PubMed ID: 3533295 [TBL] [Abstract][Full Text] [Related]
24. [Importance of night monkeys (Aotus) in research on malaria chemotherapy]. Rossan RN; Escajadillo A Rev Med Panama; 1984 Sep; 9(3):222-5. PubMed ID: 6387820 [No Abstract] [Full Text] [Related]
25. Recrudescence of Plasmodium falciparum malaria contracted in Lombok, Indonesia after quinine/doxycycline and mefloquine: case report. Tish KN; Pillans PI N Z Med J; 1997 Jul; 110(1047):255-6. PubMed ID: 9251712 [TBL] [Abstract][Full Text] [Related]
26. [Resistance of Plasmodium falciparum to antimalarials: practical implications and control prospects]. Onori E Parassitologia; 1981 Dec; 23(1-3):31-62. PubMed ID: 6760055 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Rieckmann KH; Trenholme GM; Williams RL; Carson PE; Frischer H; Desjardins RE Bull World Health Organ; 1974; 51(4):375-7. PubMed ID: 4619059 [TBL] [Abstract][Full Text] [Related]
29. [Problems of malaria therapy]. Schelp FP; Germer W Dtsch Med J; 1972 Aug; 23(8):529-32. PubMed ID: 4565047 [No Abstract] [Full Text] [Related]
30. The origins of antimalarial drug resistance. Hastings IM Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of malaria]. Boulos M Rev Paul Med; 1982; 99(1):29-30. PubMed ID: 6755621 [No Abstract] [Full Text] [Related]
32. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar. Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806 [TBL] [Abstract][Full Text] [Related]
33. Type II mefloquine resistance in Thailand. Boudreau EF; Webster HK; Pavanand K; Thosingha L Lancet; 1982 Dec; 2(8311):1335. PubMed ID: 6128616 [No Abstract] [Full Text] [Related]
34. A case of fansidar-resistant Plasmodium falciparum from Tanzania. De Geus A; Meuwissen JH; van Rijn A Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245 [No Abstract] [Full Text] [Related]
35. [Treatment of malaria in the 19th and 20th centuries]. Molfese A Clin Ter; 1999; 150(1):81-5. PubMed ID: 10367548 [No Abstract] [Full Text] [Related]
36. Drug resistance of malaria parasites in Tanzania. Clyde DF East Afr Med J; 1966 Oct; 43(10):405-8. PubMed ID: 5341684 [No Abstract] [Full Text] [Related]
37. Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei. Kazim M; Puri SK; Dutta GP Indian J Med Res; 1979 Dec; 70 Suppl():95-102. PubMed ID: 121298 [No Abstract] [Full Text] [Related]
38. [Malaria and drug resistance]. Kager PA; Wetsteyn JC Ned Tijdschr Geneeskd; 1996 Jan; 140(3):151-5. PubMed ID: 8618636 [TBL] [Abstract][Full Text] [Related]
39. [Drug resistance of Plasmodium falciparum along the borders of the highlands in Madagascar: outlook for a national control program]. Milijaona R; Raharimalala L; Ramambanirina L; Ranaivo LH; Jambou R Med Trop (Mars); 1998; 58(3):261-5. PubMed ID: 10088103 [TBL] [Abstract][Full Text] [Related]